Novo Nordisk A/S (NVO) Ownership
NVO ownership summary
as of October 18, 2026- Institutions
- 9.9% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 3.34B
- Float
- 3.17B shares available to trade
- Short interest
- 1.00% 31.6M shares short
- Days to cover
- 2.34 short interest down 0.1% vs prior month
- Institutions 9.88%
- Insiders 0.00%
- Other investors 90.11%
NVO top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Dodge & Cox | 0.46% | 20.4M | $792.0M | +1.1M (+5.5%) | June 30, 2026 |
| 2 | Loomis, Sayles & Company LP | 0.42% | 18.6M | $722.0M | +1.6M (+9.3%) | June 30, 2026 |
| 3 | Franklin Templeton Inc | 0.30% | 13.0M | $506.4M | −3.0M (−18.9%) | June 30, 2026 |
| 4 | T. Rowe Price Associates, Inc. | 0.27% | 11.7M | $454.5M | +644,039 (+5.8%) | June 30, 2026 |
| 5 | Morgan Stanley - Brokerage Accounts | 0.26% | 11.7M | $452.8M | +790,669 (+7.3%) | June 30, 2026 |
| 6 | Bank of America Corp | 0.25% | 11.2M | $434.0M | +407,013 (+3.8%) | June 30, 2026 |
| 7 | Capital Research & Mgmt Co - Division 3 | 0.22% | 9.7M | $377.5M | −2.1M (−17.6%) | June 30, 2026 |
| 8 | Folketrygdfondet | 0.22% | 9.5M | $369.8M | +441,563 (+4.9%) | June 30, 2026 |
| 9 | The Goldman Sachs Group Inc | 0.21% | 9.2M | $356.5M | +4.1M (+79.3%) | June 30, 2026 |
| 10 | Fisher Asset Management, LLC | 0.19% | 8.3M | $323.3M | −696,155 (−7.7%) | June 30, 2026 |
| 11 | Arrowstreet Capital Limited Partnership | 0.19% | 8.3M | $321.2M | +443,294 (+5.7%) | June 30, 2026 |
| 12 | Everett Harris & Co | 0.15% | 6.5M | $251.4M | +50,961 (+0.8%) | June 30, 2026 |
| 13 | State Farm Mutual Automobile Ins Co | 0.14% | 6.1M | $238.5M | — | June 30, 2026 |
| 14 | State Street Corp | 0.13% | 5.9M | $227.9M | +32,641 (+0.6%) | June 30, 2026 |
| 15 | Royal Bank of Canada | 0.12% | 5.4M | $209.6M | +871,282 (+19.2%) | June 30, 2026 |
| 16 | Capital World Investors | 0.12% | 5.2M | $202.1M | −3,501 (−0.1%) | June 30, 2026 |
| 17 | Fred Alger Management, LLC | 0.11% | 4.9M | $190.6M | +4.9M (0.0%) | June 30, 2026 |
| 18 | Susquehanna International Group, LLP | 0.11% | 4.8M | $187.0M | −6.3M (−56.6%) | June 30, 2026 |
| 19 | Wells Fargo & Co | 0.11% | 4.7M | $180.9M | +1.0M (+27.9%) | June 30, 2026 |
| 20 | UBS Group AG | 0.09% | 4.0M | $154.7M | −580,768 (−12.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 16.3M shares and 6 cut 12.7M.
NVO top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Stock I | 0.35% | 15.2M | $591.8M | — | June 30, 2026 |
| 2 | Putnam Large Cap Value A | 0.18% | 8.0M | $309.7M | — | August 31, 2026 |
| 3 | American Funds Washington Mutual A | 0.12% | 5.3M | $207.3M | — | June 30, 2026 |
| 4 | Loomis Sayles Growth Y | 0.11% | 5.1M | $196.8M | −109,136 (−2.1%) | August 31, 2026 |
| 5 | American Funds American Balanced A | 0.11% | 4.8M | $184.4M | — | June 30, 2026 |
| 6 | MUAM Foreign Equity Index Mother | 0.08% | 3.5M | $137.3M | +3.5M (0.0%) | May 20, 2026 |
| 7 | T. Rowe Price International Stock | 0.04% | 1.8M | $71.8M | −648,335 (−26.0%) | August 31, 2026 |
| 8 | Loomis Sayles US Growth Eq I/A USD | 0.04% | 1.8M | $69.8M | +73,245 (+4.2%) | August 31, 2026 |
| 9 | Alger Focus Equity I | 0.04% | 1.8M | $68.9M | +301,497 (+20.5%) | July 31, 2026 |
| 10 | CREF Total Global Stock Account R3 | 0.04% | 1.7M | $67.8M | +206,829 (+13.4%) | July 31, 2026 |
| 11 | T. Rowe Price Equity Income | 0.04% | 1.7M | $64.7M | −176,000 (−9.6%) | August 31, 2026 |
| 12 | VanEck Pharmaceutical ETF | 0.03% | 1.5M | $58.6M | −8,109 (−0.5%) | September 30, 2026 |
| 13 | Avantis International Equity ETF | 0.03% | 1.3M | $52.3M | +14,740 (+1.1%) | September 30, 2026 |
| 14 | Dodge & Cox Balanced I | 0.03% | 1.3M | $49.5M | — | June 30, 2026 |
| 15 | Bridge Builder Large Cap Value | 0.03% | 1.3M | $49.0M | +29,500 (+2.4%) | September 30, 2026 |
| 16 | DFA International Core Equity 2 I | 0.02% | 929K | $36.1M | — | August 31, 2026 |
| 17 | BrighthouseI Loomis Sayles Growth Cl B | 0.02% | 904K | $35.1M | +103,882 (+13.0%) | June 30, 2026 |
| 18 | First Trust WCM International Equity ETF | 0.02% | 808K | $31.4M | +3,339 (+0.4%) | September 30, 2026 |
| 19 | Alger Spectra A | 0.02% | 794K | $30.8M | +332,554 (+72.1%) | July 31, 2026 |
| 20 | Nuveen Dividend Value A | 0.02% | 730K | $28.3M | +374,405 (+105.4%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NVO shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NVO
Institutional investors own 9.9% of Novo Nordisk A/S's shares and insiders 0.00%. The largest holder is Dodge & Cox with 0.46% of the shares (20.4M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 6 reduced their stake in the latest filings. Short interest is 1.00% of the float, or 2.34 days of average trading volume. The share count fell 15.3% since 2014.
Related: NVO analyst forecast, NVO key metrics, NVO dividend history. See the NVO stock overview for the latest quote and news.
NVO ownership FAQ
Who owns the most Novo Nordisk A/S stock?
The largest shareholders of Novo Nordisk A/S are Dodge & Cox (0.46%), Loomis, Sayles & Company LP (0.42%), Franklin Templeton Inc (0.30%), T. Rowe Price Associates, Inc. (0.27%), Morgan Stanley - Brokerage Accounts (0.26%).
What percentage of Novo Nordisk A/S is owned by institutions?
Institutions hold 9.9% of Novo Nordisk A/S's shares outstanding; insiders hold 0.00%.
Which funds own Novo Nordisk A/S?
The largest fund holders of Novo Nordisk A/S are Dodge & Cox Stock I (0.35%), Putnam Large Cap Value A (0.18%), American Funds Washington Mutual A (0.12%), Loomis Sayles Growth Y (0.11%), American Funds American Balanced A (0.11%).
What is Novo Nordisk A/S's short interest?
31.6M shares of Novo Nordisk A/S were sold short, 1.00% of the float; at the average daily volume it would take 2.34 days to cover.
How many shares of Novo Nordisk A/S are outstanding?
Novo Nordisk A/S has 3.34B shares outstanding, of which 3.17B are in the public float.